This research report scrutinizes the Global BCG Vaccine Industry. It studies all the characteristic of the present and forthcoming industry which is climacteric for all new participants well as the leading market participants.
- Advertising -
The Global BCG Vaccine market size was around USD 0.021 million in 2017. It is expected to grow at a CAGR of 4.6% to reach USD 0.03 million by 2022.
BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that.
- Advertising -
A single dose is given to an infant soon after birth in countries with high occurrence of TB. In countries which TB is not a common occurrence only high risk infants are treated with it.
Adults are only treated with this vaccine if their exposure to drug-resistant TB is a regular occurrence.
Increasing number of cases of TB all over the world particularly in the developing countries of APAC, rapid advancements in technology in the field of medical research on vaccines, and savoury government policies and initiatives with improved funding are driving the growth of this market.
Adverse side-effects of this vaccine and supply bottlenecks all around the world are expected to hinder market growth in the forecast period.
The market segmentation is very broad and is only classified by demographics into Paediatrics (0-18 years), and Adults (19-35 years). Paediatrics is a clear market leader accounting for more than three quarters of market share and is likely to gain even more in the forecast period.
It is because BCG vaccination has become mandatory in most of the countries as part of the national immunization program. Moreover, the efficacy of the vaccine is reduced if it is not administered in infancy.
The usage of this vaccine is highest in Kenya. Polio and hepatitis B vaccines are usually administered alongside it.
Classification by geography entails North America, Latin America, Europe, Asia Pacific and Middle East and Africa. North America accounted for the largest market share while Asia Pacific is expected to grow with the highest CAGR due to TB eradication campaigns going on in the developing countries.
Key players in the market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory. Other players in the market include China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt.
Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute.
Make an enquiry @ orbisresearch.com/contacts/enquiry…re-buying/2086165
Some Point from Table of Content:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
- Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
Category: Market Research Publishers and RetailersCompany about: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...
For more information: